07th week of 2015 patent applcation highlights part 52 |
Patent application number | Title | Published |
20150045385 | BRAIN FUNCTION IMPROVING AGENT - The present invention provides a pharmaceutical composition used in improving brain function including a compound of formula (I). | 2015-02-12 |
20150045386 | (2S,3R)-N-2-3-PYRIDINYLMETHYL-1-AZABICYCLO 2.2.2 OCT-3-YL BENZOFURAN-2-CARBOXAMIDE, NOVEL SALT FORMS, AND METHODS OF USE THEREOF - The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems. | 2015-02-12 |
20150045387 | Bi-Aromatic And Tri-Aromatic Compounds As NADPH Oxidase 2 (Nox2) Inhibitors - Bi- and tri-aromatic compounds of the formula (I) wherein R1 to RIO and X are as defined, are Nox2 inhibitors that are useful as medicaments for the treatment of a disease or condition selected from: cardiovascular diseases, respiratory diseases, inflammatory diseases, cancers, ageing and age related disorders, kidney diseases, neurodegenerative diseases, diabetes and conditions associated with diabetes. The compounds, their preparation and pharmaceutical compositions comprising them are disclosed. | 2015-02-12 |
20150045388 | TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY - A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a drug to the back of the neck of a human patient at the hairline in close proximity to and under or on the area of skin above the brain stem to provide regional neuro-affective therapy is disclosed. | 2015-02-12 |
20150045389 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR - The present invention is a screening assay for identifying inhibitors of | 2015-02-12 |
20150045390 | ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS - R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic. | 2015-02-12 |
20150045391 | FILANESIB COMBINED WITH POMALIDOMIDE DISPLAYS ENHANCED ANTI-TUMOR ACTIVITY - A combination of filanesib and pomalidomide for treating patients is provided. | 2015-02-12 |
20150045392 | METHODS OF TREATING PRURITIC CONDITIONS MEDIATED THROUGH HISTAMINE H-4 RECEPTORS - The methods disclosed herein relate to the treatment of histamine H-4—related pruritus, by administering a histamine H-4 receptor inverse agonist that selectively accumulates at the biophases of the disorders, specifically RS-norketotifen or a pharmaceutically acceptable salt thereof. Potentiated antipruritic activity by simultaneous inhibition of histamine H-1 receptors and histamine H-4 receptors are described. | 2015-02-12 |
20150045393 | Novel Cysteine Protease Inhibitors and Uses Thereof - The invention provides for novel cysteine protease inhibitors and compositions comprising novel cysteine protease derivatives. The invention further provides for methods for treatment of neurodegenerative diseases comprising administration novel cysteine protease inhibitors or compositions comprising novel cysteine protease inhibitors. In some embodiments, the cysteine protease inhibitors are calpain inhibitors. | 2015-02-12 |
20150045394 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS - The present invention relates to novel carboxamide compounds and their use as a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity and to a method for the therapeutic and/or prophylactic treatment by administering an effective amount of at least one of these carboxamide compounds. | 2015-02-12 |
20150045395 | METHOD OF USING AN INDOLINONE MOLECULE AND DERIVATIVES FOR INHIBITING LIVER FIBROSIS AND HEPATITIS - This invention relates to methods of reversing and inhibiting liver fibrosis and hepatitis using a small indolinone molecule Hesperadin and related compounds. Methods of identifying such agents and using them to inhibit the expression of collagens and ECM proteins including MMPs and TIMPs in purified hepatic stellate cells are provided. In vivo data of Hesperadin in inhibiting induced collagen production are presented. This method of specifically targeting drugs to hepatic stellate cells in vivo, provides a novel therapy for liver diseases. | 2015-02-12 |
20150045396 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR GIANT CELL TUMORS OCCURRING IN BONE AND SOFT TISSUE OR FOR CHONDROSARCOMA - The present invention provides a prophylactic or therapeutic agent for giant cell tumors occurring in a bone and soft tissue or for chondrosarcoma, which comprises a non-steroidal anti-inflammatory agent or thiazolidine derivative as an active ingredient, and the like | 2015-02-12 |
20150045397 | SUBSTITUTED PYRIDINES AS SODIUM CHANNEL BLOCKERS - The invention relates to substituted pyridine and pyrimidine compounds of Formula (I) and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein R | 2015-02-12 |
20150045398 | ArylSulfonamide-Based Matrix Metalloprotease Inhibitors - The present invention provides a compound of formula (I): | 2015-02-12 |
20150045399 | Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions - Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds. | 2015-02-12 |
20150045400 | RITONAVIR COMPOSITIONS - The present invention relates to pharmaceutical compositions comprising ritonavir premix, a water soluble polymer and a surfactant and process for preparing the same. More particularly, the present invention relates to hot-melt extrusion process for preparing solid oral compositions of ritonavir premix. | 2015-02-12 |
20150045401 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE - Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain cancer, and prostate cancer through the release of riluzole. Prodrugs of riluzole have enhanced stability to hepatic metabolism and are delivered into systemic circulation by oral administration, and then cleaved to release riluzole in the plasma via either an enzymatic or general biophysical release process. | 2015-02-12 |
20150045402 | HETEROCYCLIC ACETAMIDE COMPOUND - A compound which is useful as a dopamine D1 receptor positive allosteric modulator (D1 PAM) is provided. The present inventors have studied a compound which has a dopamine D1 receptor positive allosteric modulating activity and is useful as an active ingredient of a pharmaceutical composition for preventing and/or treating cognitive impairment, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug addictions, or the like, and they have thus found that a heterocyclic acetamide compound has a dopamine D1 receptor positive allosteric modulating activity, thereby completing the present invention. The heterocyclic acetamide compound of the present invention has a dopamine D1 receptor positive allosteric modulating activity and can be used as an agent for preventing and/or treating cognitive impairment, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug addictions, or the like. | 2015-02-12 |
20150045403 | Pharmaceutical Cream Compositions and Methods of Use - Embodiments relating to cream formulations as well as oxymetazoline creams and methods for treating rosacea and symptoms associated with rosacea, including, for example, papules, pustules, phymas (skin thickening), telangiectasias or erythema associated with rosacea, other skin erythemas, telangiectasias, purpura or the like, and other manifestations associated therewith; other inflammatory conditions of the skin including, but not limited to, keratosis pilaris, lupus miliaris dissemniatus faciei, eczema, dermatitis, such as contact dermatitis, atopic dermatitis, seborrheic dermatitis, nummular dermatitis, generalized exfoliative dermatitis, statis dermatitis, neurodermatitis, lichen simplex chronicus, xerosis and xerotic dermatitis, dyshidrosis and dyshidrotic dermatitis, asteototic dermatitis or other conditions characterized by sensitive skin or a disturbance of the epidermal barrier; disorders characterized by rough, dry, cracked or fissured skin, disorders characterized by hyperkeratotic skin such as keratodermas and ichthyosisis and ichthyosiform dermatoses; disorders of hair follicles and sebaceous glands, such as acne, perioral dermatitis, and pseudofolliculitis barbae; disorders of sweat glands, such as miliaria, including, but not limited to, miliaria crystallina, miliaria rubra, miliaria profunda, miliaria pustulosa; sunburn, chronic actinic damage, poikiloderma, radiation dermatitis, actinic purpura (“solar purpura”); other inflammatory dermatoses, reactions and conditions of the skin, including, but not limited to, psoriasis, drug eruptions, erythema multiforme, erythema nodosum, and granuloma annulare; diseases and conditions characterized by bleeding or bruising such as petechiae, ecchymosis, purpura and the like including any accumulation of blood in the skin due to vascular extravasation, irrespective of size or cause, bleeding or bruising due to any skin injury which may include any trauma including surgical or procedural trauma; infection, inflammatory dermatoses or inflammation due to any cause using such creams are described herein. | 2015-02-12 |
20150045404 | SCHWEINFURTHIN ANALOGUES - The invention provides a compound of formula (I): wherein R | 2015-02-12 |
20150045405 | CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride - An improved AKT inhibiting compound, crystalline N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride. | 2015-02-12 |
20150045406 | CURAXINS FOR USE IN TREATING BREAST CANCER AND METHOD FOR IDENTIFING PATIENTS LIKELY TO RESPOND - The present invention relates to the treatment of breast cancer which is estrogen receptor positive (ER | 2015-02-12 |
20150045407 | MTK1-ACTIN INHIBITORS AND METHODS OF USE - One aspect of the invention provides a method for treating a clinical condition associated with inappropriate or abnormal activation of HER3/ErbB3. In some embodiments, the method of the invention inhibits interaction between MTK1 and actin. | 2015-02-12 |
20150045408 | (3,4-DICHLORO-PHENYL)-((S)-3-PROPYL-PYRROLIDIN-3-YL)-METHANONE HYDROCHLORIDE AND MANUFACTURING PROCESSES - The present invention is concerned with a novel process for the preparation of a compound of formula I and its hydrates | 2015-02-12 |
20150045409 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL - An amide compound represented by formula (I) has an excellent pest control effect. (In the formula, Y represents a 3-7 membered saturated heterocyclic ring which contains, as ring-forming components(s), one or more atoms or groups that are selected from the group consisting of an oxygen atom and —S(O) | 2015-02-12 |
20150045410 | METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING - The present invention relates to therapeutic agents comprising miR-138, a miR-138 mimic, a SIN3A RNAi molecule, or a an anti-SIN3A RNAi molecule, and/or an anti-SIN3A antisense oligonucleotide (ASO) or other agent that suppresses SIN3A expression, a small molecule drug that interferes with SIN3A activity or whose actions mimic the biological effects of SIN3A suppression and methods of use of these therapeutic agents to treat cystic fibrosis. | 2015-02-12 |
20150045411 | PAIN TREATMENT - The disclosure relates to an RNA interference (RNAi) agent and the use of that RNAi agent to treat chronic pain in individuals, as well as pharmaceutical compositions containing the RNAi agents of the invention. The DNA-directed RNA interference (ddRNAi) agent for inhibiting expression of one or more target sequences in a pain associated gene comprises, one or more effector sequence sequences and effector complement sequences of at least 17 nucleotides in length, wherein the effector sequence is substantially complementary to the predicted transcript of a target sequence within a pain associated gene. | 2015-02-12 |
20150045412 | USE OF THE CHROMOSOME 19 MICRORNA CLUSTER (C19MC) FOR TREATING MICROBIAL DISEASE AND PROMOTING AUTHOPHAGY - It is disclosed herein that cultured primary placental human trophoblast (PHT) cells are highly resistant to infection by a number of disparate viruses, and confer this resistance to non-placental recipient cells by exosome-mediated delivery of microRNAs (miRs). PHT cells express high levels of unique, primate-specific miRNAs, expressed from the chromosome 19 miRNA cluster (C19MC). It is further disclosed herein that C19MC miRNAs are packaged within PHT-derived exosomes and attenuate viral replication in recipient cells by inducing autophagy. Thus, provided herein are methods of inhibiting, treating or preventing microbial infections by administering one or more miRs of the C19MC. Also provided are methods of inducing autophagy in a cell by contacting the cell with one or more miRs of the C19MC. | 2015-02-12 |
20150045413 | RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy - The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing and/or delaying DMD or BMD. | 2015-02-12 |
20150045414 | TRANS-ACTING RNA SWITCHES - Disclosed are RNA constructs which function to activate or inactivate a biological process, e.g., may be designed for attachment to a polypeptide coding region. Such RNA constructs modulate translation of a polypeptide from the coding region in response to the presence of a target polynucleotide in an expression environment. Such RNA constructs include a weakened stem-loop structure which, when bound to the target polynucleotide, assumes stem-loop secondary structure and associates with an RNA binding protein. Association with the RNA binding protein modulates translation of the polypeptide coding region. Such RNA constructs also have three-way junction joining regions 3′ and 5′ of the stem-loop structure. | 2015-02-12 |
20150045415 | Oligomers - Certain disclosed oligomers induce exon skipping during processing of myostatin pre-mRNA. The oligomers may be in a vector or encoded by the vector. The vector is used for inducing exon skipping during processing of myostatin pre-mRNA. A therapeutically effective amount of the oligomer may be administered to a subject patient such that exon skipping during processing of myostatin pre-mRNA is induced. The administration to a subject may be used in order to increase or maintain muscle mass, or slowing degeneration of muscle mass in the subject. The administration to a subject may ameliorate muscle wasting conditions, such as muscular dystrophy. Examples of such muscular dystrophies which may be so treated include Becker's muscular dystrophy, congenital muscular dystrophy, Duchenne muscular dystrophy, distal muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy (FSHD), limb-girdle muscular dystrophy, myotonic muscular dystrophy, and oculopharyngeal muscular dystrophy | 2015-02-12 |
20150045416 | Methods and Compositions for Gene Delivery - Disclosed herein are AAV-based viral vectors encoding GNE from muscle-specific and non-muscle specific promoters, and the use of same in treating myopathies associated with altered GNE function. | 2015-02-12 |
20150045417 | A NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP - The invention relates to VLP derived from human polyoma virus loaded with a drug (cargo) as a drug delivery system for transporting said drug into the CNS, in particular of living humans. | 2015-02-12 |
20150045418 | METHODS AND MATERIALS FOR TREATING CANCER - This document provides methods and materials for treating cancers including renal cancer (e.g., renal cell carcinoma) as well as ovarian, breast, prostate, colon, pancreatic, bladder, liver, lung, and thyroid cancers and melanoma. For example, methods and material for using one or more inhibitors of an SCD1 polypeptide to treat renal cell carcinoma (e.g., clear cell renal cell carcinoma (ccRCC)) or to increase the efficacy of a renal cell carcinoma treatment are provided. In addition, this document provides methods and materials for using elevated SCD1 expression levels in diseased tissues as an indication that an SCD1 inhibitor can be used as an appropriate therapeutic to ameliorate the disease. | 2015-02-12 |
20150045419 | REVERSIBLY CROSSLINKED MICELLE SYSTEMS - The present invention provides amphiphilic telodendrimers that aggregate to form nanocarriers characterized by a hydrophobic core and a hydrophilic exterior. The nanocarrier core may include amphiphilic functionality such as cholic acid or cholic acid derivatives, and the exterior may include branched or linear poly(ethylene glycol) segments. Nanocarrier cargo such as hydrophobic drugs and other materials may be sequester in the core via non-covalent means or may be covalently bound to the telodendrimer building blocks. Telodendrimer structure may be tailored to alter loading properties, interactions with materials such as biological membranes, and other characteristics. | 2015-02-12 |
20150045420 | SKIN CARE COMPOSITIONS HAVING CYCLIC DIESTERS AND METHODS THEREOF - The present invention generally relates to topical skin care compositions having at least one cyclic diester. More specifically, the present invention relates to novel topical skin care compositions having at least one cyclic diester of an alpha hydroxy acid, and at least one polar non-aqueous solvent. | 2015-02-12 |
20150045421 | SKIN CARE COMPOSITIONS HAVING CYCLIC DIESTERS AND METHODS THEREOF - The present invention generally relates to topical skin care compositions having at least one cyclic diester. More specifically, the present invention relates to novel topical skin care compositions having at least one cyclic diester of an alpha hydroxy acid, and at least one polar non-aqueous solvent. | 2015-02-12 |
20150045422 | Influenza treatment using targeted transient ribosomal inhibition - Novel methods are presented for treating Influenza by using Targeted Transient Ribosomal Inhibition (TTRI), with TTRI drugs administered by inhalation, to silence expression of every protein underlying the etiology and pathology of the influenza infection, and without adversely effecting normal cells in the lungs. The therapeutic effect is dual Antiviral and Anti-Inflammatory activity which is localized to the lungs. Pulmonary TTRI for influenza silences expression of all 10 influenza viral proteins and de novo synthesis of cytokines and leukotrienes produced in the lungs. By targeting ribosomes, TTRI is insensitive to viral mutations or human alterations to the virus. TTRI provides an off-the-shelf solution for preventing mortality from any strain of influenza. | 2015-02-12 |
20150045423 | COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF OSTEOARTHROSIS - The present invention relates to new compounds which are inter alia derivable from hops for use in the treatment of (for treating)/prevention or healing of a disease which is associated with an excess transport of hyaluronan across a lipid bilayer, in particular a disease which is associated with or characterized by degeneration and/or a destruction of cartilage (and/or for the prevention of aggrecan loss). Food products comprising these compounds for use in the treatment (for treating) a disease which is associated with an excess transport of hyaluronan across a lipid bilayer, in particular a disease which is associated with or characterized by degeneration and/or a destruction of cartilage, are also envisaged. | 2015-02-12 |
20150045424 | COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES - It is described the use of L-carnitine and/or an alkanoyl L-carnitine, or a pharmaceutically acceptable salt thereof, in combination with a statin, for the preparation of a medicament for the treatment of type 2 diabetes. | 2015-02-12 |
20150045425 | PELTATIN AND METABOLIC DISORDERS - The present invention relates to the field of metabolic disorders and aims to identify natural compounds that can be used effectively in this field. In particular, the present invention provides a composition comprising at least one peltatin for use in the treatment or prevention of metabolic disorders or risk factors thereof. | 2015-02-12 |
20150045426 | VITAMIN C COMPLEXES - A complex formed of at least one molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or a derivative covalently bonded with at least one hydrocarbon radical with formula (A) as follows: wherein: •-m 1=1, 2, 3, 4, 5 or 6; •-m 2=0, 1, 2, 3, 4, 5 or 6; and represents the site of the bond with the molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or derivative. Formula (I) | 2015-02-12 |
20150045427 | Oxaspiro[2.5]Octane Derivatives and Analogs - The invention provides oxaspiro[2.5]octane derivatives and analogs, methods for preparation thereof, intermediates thereto, pharmaceutical compositions, and uses thereof in the treatment of various disorders and conditions, such as overweight and obesity. | 2015-02-12 |
20150045428 | LIGAND-TARGETED MOLECULES AND METHODS THEREOF - The present invention relates to ligand-targeted molecules and ligand drug conjugates (LDCs) comprising a ligand connected to a functional group, which is connected to a linker, which in turn is bonded to a drug. The LDCs of the present invention also comprise platinum coordination complex wherein the platinum is connected to the linker through monocarboxylato and O→Pt coordinate bonds. The present invention also relates to methods for preparing these ligand drug conjugates. The present invention further relates to methods for the treatment of tumours using the ligand drug conjugates of the present invention. | 2015-02-12 |
20150045429 | HYDRATING COMPOSITION, USE OF A COMPOSITION AND COSMETIC FORMULATION CONTAINING A HYDRATING COMPOSITION - The present invention describes a new moisturizing composition comprising a mixture of esters of one or more alkoxylated polyols and finds use in the formulation of cosmetics for the skin. The composition of the present invention can be in the solid form or in the liquid form, in which case is also comprises one or more surfactants, emollients and, optionally, water. The moisturizing composition described herein is compatible with a large variety of emollients and additional ingredients used in cosmetic formulations, and has shown to be able to maintain the skin hydrated for 24 hours. | 2015-02-12 |
20150045430 | COMPOSITIONS AND PRODUCTS CONTAINING ESTOLIDE COMPOUNDS - Estolide compounds that may be suitable for use in personal care and cosmetic formulations, and method of preparing the same. The estolides can be tailored to exhibit the desired viscometric and lubricity properties, while retaining or even improving other properties desirable in such products. | 2015-02-12 |
20150045431 | METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing triglycerides in a subject on Apo-C3 modulating therapy, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2015-02-12 |
20150045432 | DIETARY SUPPLEMENT COMPRISING AMINO ACIDS IN A PALATABLE LIQUID FORMULATION THAT PROMOTES RESTFUL SLEEP, RECOVERY FROM STRESS AND EXERCISE AND STRENGTHENS THE IMMUNE SYSTEM - A palatable, single serving dietary supplement of amino acids that may be taken as a nutritional aid to improve health and well-being by promoting higher quality sleep, enhancing repair of muscular tissue after strenuous exercise in part through boosting the natural production of human growth hormone, enhancing the immune system, improve gut barrier function, aiding in responses to upper respiratory viral pathogens, reversing side effects from the over use of nutritional energy drinks with stimulants and simple sugars and reverse the side effects of excess signaling through the cortisol pathway resulting from chronic environmental stress. | 2015-02-12 |
20150045433 | METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY - Methods and compositions are provided for inducing physiologic hypertrophy in a cell for treatment or prevention of a cardiovascular disease or condition. | 2015-02-12 |
20150045434 | METHIONINE COMPOUND INTENDED FOR ANIMAL FEED - The present invention relates to a novel liquid methionine composition, originating from the mother liquor from crystallization of methionine produced by fermentation, comprising between 30 and 50% by weight of methionine and having a dry matter comprised between 20% and 75% by weight and characterized in that it also comprises less than 0.5% by weight of isoleucine and between 0.9% and 1.3% of N-acetyl-methionine. | 2015-02-12 |
20150045435 | COMPOUNDS AND METHODS FOR TREATING DIABETES - The invention described herein pertains to compounds, compositions, methods and uses thereof. The compounds described herein are in a class of glucose-lowering drugs useful for treating diabetes. Generally, compounds of the Formula I are described herein. | 2015-02-12 |
20150045436 | Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R | 2015-02-12 |
20150045437 | TRANSDERMAL DELIVERY KITS - Provided are kits containing a base composition and an active pharmaceutical ingredient for transdermal delivery of active pharmaceutical ingredients. Examples of active pharmaceutical ingredients include amitriptyline, baclofen, cyclobenzaprine HCl, ibuprofen, lidocaine HCl, naproxen and tramadol, ketoprofen, diclofenac, phenylbutazone, mefenamic acid, flubiprofen, piroxicam, guaifenasin, prilocaine, bupivicaine, tetracaine, nifedipine, verapamil, orphenadrine, imipramine, ketamine, gabapentin, carbamazepine, menthol, capsaicin, clonidine, dexamethasone, dextromethorphan, testosterone, progesterone, and estrogens. | 2015-02-12 |
20150045438 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2015-02-12 |
20150045439 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2015-02-12 |
20150045440 | METHOD FOR THE TREATMENT OF ACNE USING PHARMACEUTICAL COMPOSITIONS COMPRISING 0.3% BY WEIGHT OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID - Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions. | 2015-02-12 |
20150045441 | Crystalline Diacylhydrazine and the Use Thereof - The present disclosure provides crystalline polymorphic and amorphous forms of (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 1) or (S)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 2). The present disclosure further provides compositions comprising crystalline polymorphic and amorphous forms of Compound 1 or Compound 2 and an excipient, methods of making crystalline polymorphic or amorphous forms of Compound 1 or Compound 2, and methods of using crystalline polymorphic or amorphous forms of Compound 1 or Compound 2 to regulate gene expression in a cell or in a subject. | 2015-02-12 |
20150045442 | NOVEL MELATONIN LIGANDS HAVING ANTIDEPRESSANT ACTIVITY AS WELL AS SLEEP INDUCING PROPERTIES - Novel melatonin ligands of Formula I: | 2015-02-12 |
20150045443 | USING AN UNSUBSTITUTED QUATENARY AMMONIUM SALT COMPOSITION WITH OTHER INGREDIENTS AS A SKIN SANITIZING SOLUTION AND NATURAL SKIN CONDITIONER - A water based, alcohol-free, skin sanitizing solution with a natural skin softener, where the nature of the biocidal enhancer used in the process of making the solution significantly increases efficacy while simultaneously enabling much more economical manufacturing, processing and transportation of the product. Because it is water based, no further moisturizing additives are required, and those with sensitive skin, diabetes, allergies or religious beliefs are able to use the product without concern. | 2015-02-12 |
20150045444 | ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions. | 2015-02-12 |
20150045445 | 3-KETO-N-PROPARGYL-1-AMINOINDAN - The subject invention provides a pharmaceutical composition containing N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of 3-keto-N-propargyl-1-aminoindan or a salt thereof. | 2015-02-12 |
20150045446 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2015-02-12 |
20150045447 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2015-02-12 |
20150045448 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2015-02-12 |
20150045449 | METHOD FOR ISOLATING POLYPHENOLS FROM OLIVE MILL WATER - The present invention relate to a highly efficient and novel method, using clean technologies, for obtaining a natural bioactive concentrate that is rich on polyphenols from olive mill water (OMW). The clean technologies integrate centrifugation, a drowning-out crystallization-based separation process, and vacuum evaporation. The method provides a highly-concentrated polyphenol isolate (up to 99% (mass fraction)) from other components presents in OMW, with up to half of the polyphenol content being hydroxytyrosol. The isolated polyphenols exhibit anti-oxidant, anti-microbial, anti-inflammatory, and anti-carcinogenic activities; they can be prepared as solid particles, as an aqueous solution, in an emulsion, or as lipidic-based nanoparticles. The isolated polyphenols can be used in the food industry, cosmetic industry, or pharmaceutical industry. | 2015-02-12 |
20150045450 | NANOPARTICLES OF A METAL AND A NUCLEOBASE - A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising a metal ion, a nucleobase, an oxidant, and water, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of nanoparticles. Biocompatible nanoparticles comprised of cerium or iron as the metal ion, and a purine and/or a pyrimidine as the nucleobase, are described. | 2015-02-12 |
20150045451 | POLYMERIC BIOMATERIALS DERIVED FROM MONOMERS COMPRISING HYDROXYACIDS AND PHENOL COMPOUNDS AND THEIR MEDICAL USES - The present invention provides new classes of phenolic compounds derived from hydroxyacids and tyrosol or tyrosol analogues, useful as monomers for preparation of biocompatible polymers, and the biocompatible polymers prepared from these monomeric hydroxyacid-phenolic compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric hydroxyacid-phenolic compounds and biocompatible polymers. | 2015-02-12 |
20150045452 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE - The present application provides an orally-disintegrating tablet having excellent tablet hardness and disintegrability. The present application further provides a method of producing a disintegrative particulate composition including three components consisting of a first disintegrator component of an acid-type carboxymethylcellulose, a second disintegrator component and an excipient. The method includes a first wet granulation step using any two of the three components, and a second wet granulation step using granules obtained in the first wet granulation step and the remaining one component of the three components not used in the first wet granulation step. The production method may further includes a crystalline cellulose as a fourth component or a third step of mixing a crystalline cellulose into granules obtained in the second wet granulation step. Disintegrative particulate compositions obtained by these methods are also disclosed. | 2015-02-12 |
20150045453 | EMULSIFIED FOOD PRODUCT COMPOSITION - The purpose of the present invention is to provide an emulsified food product composition having good fluidity and emulsification stability, even when subjected to heat sterilization treatment, with which gastro-esophageal reflux can be prevented by gelling upon entering the stomach. By adding a gelling agent for gelling in the acidic region, at least one emulsion stabilizer selected from the group consisting of gum arabic and gum ghatti, and a divalent metal salt to the emulsified food product composition comprising a lipid, it is possible to realize the property of gelling upon entering the stomach and obtain good fluidity and emulsification stability, even if a heat sterilization treatment is used. | 2015-02-12 |
20150045454 | METHODS AND COMPOSITIONS RELATING TO STARCH FIBERS - Methods are provided according to aspects of the present invention for making starch fiber or particle compositions by wet-electrospinning or wet-electrospraying including providing a solution or dispersion of starch in an aqueous or non-aqueous solvent or dispersant, where the starch is present at a concentration above the critical entanglement concentration, with the proviso that the aqueous or non-aqueous solvent or dispersant does not consist only of water; heating the solution or dispersion of starch to a temperature above the crystallization temperature of the starch; electro spinning or electro spraying the heated solution or dispersion of starch to produce starch fibers or starch particles, respectively; and contacting the starch fibers or starch particles with a coagulation bath fluid. | 2015-02-12 |
20150045455 | CO-PRECIPITATION METHOD - Methods for preparing a PEG composition by co-precipitation of two or more components to produce a substantially homogenous powder. According to some embodiments, the two or more components are at least and partially soluble in a solvent, and at least one component is a functionalized PEG. Contacting the at least two component with the solvent at least partially dissolves the components which are then co-precipitated. The resulting product is substantially homogenous, unlike product made by other methods. The PEG composition may be co-precipitated with additional compounds, such as a colorant like indocyanine green. | 2015-02-12 |
20150045456 | METHOD FOR PRODUCING DIMETHYL ETHER FROM METHANE - The invention relates to processes for production of dimethyl ether from methane or natural gas comprising: a dry-reforming step, wherein methane and carbon dioxide are converted into carbon monoxide and hydrogen, and a DME synthesis step, wherein the carbon monoxide and hydrogen formed in the dry-reforming step are converted into dimethyl ether, wherein the dry-reforming step and the synthesis step are carried out at identical pressures or at pressures, which do not differ more than 3 bar, preferably not more than 1 bar. | 2015-02-12 |
20150045457 | DEVICE FOR THE TREATMENT OF CRUDE SYNTHESIS GAS - A device for treating steam-saturated crude gases from the entrained flow gasification of fuels before entry into heat exchanges sited upstream of a crude gas converting operation. To avoid solid deposits in an entrance region of the heat exchangers, a crude gas is converted from a saturated into the superheated state by supply of hot gas. Hot gas contemplated is superheated high pressure steam or recycled superheated converted crude gas. | 2015-02-12 |
20150045458 | METHOD AND DEVICE FOR CONVERTING CARBON DIOXIDE IN FLUE GAS INTO NATURAL GAS - A method for converting carbon dioxide in flue gas into natural gas using dump energy. The method includes: 1) transforming and rectifying a voltage of dump energy generated from a renewable energy plant, introducing the voltage-transformed and rectified dump energy into an electrolyte solution to electrolyze water therein to yield H | 2015-02-12 |
20150045459 | INTEGRATED MICROCHANNEL SYNTHESIS AND SEPARATION - An integrated microchannel reactor and heat exchanger comprising: (a) a waveform sandwiched between opposing shim sheets and mounted to the shim sheets to form a series of microchannels, where each microchannel includes a pair of substantially straight side walls, and a top wall formed by at least one of the opposing shim sheets, and (b) a first set of microchannels in thermal communication with the waveform, where the waveform has an aspect ratio greater than two. | 2015-02-12 |
20150045460 | PROCESS FOR SYNTHESIS OF ALCOHOLS - Process for the catalytic production of alcohol products, wherein by-products comprising ketone, aldehyde and ester compounds contained in the alcohol product are subjected to hydrogenation with a hydrogen-containing purge gas. | 2015-02-12 |
20150045461 | METHOD FOR RECLAIMING USED SUPERABSORBENT POLYMER - A method enabling a used superabsorbent polymer recovered from used absorbent, etc., to be readily and inexpensively recovered without using acids or alkalies. The used superabsorbent polymer is treated with an aqueous solution of a multivalent metal salt such as calcium chloride, etc., the superabsorbent polymer treated with the aqueous solution of a multivalent metal salt is treated with an aqueous solution of an alkaline metal salt such as sodium chloride, etc., the superabsorbent polymer treated with the aqueous solution of an alkaline metal salt is washed with water, and the superabsorbent polymer washed with water is then dried. | 2015-02-12 |
20150045462 | VAPOR PHASE ASSISTED POST-CONSUMER POLYMER PROCESSING APPARATUS AND METHOD - Embodiments of the invention provide a process for processing post-consumer polymer. The polymer is contacted with a control medium having a carrier gas and a reactive vapor. Such a process is useful for processing post-consumer polymers with lower energy and reactants than with liquid reactants, and also promotes decontamination of the recycled polymer during the reaction. | 2015-02-12 |
20150045463 | Hollow Nano-Particles and Method Thereof - The invention provides a hollow nano-particle comprising a crosslinked shell and a void core; and a preparation method thereof. The hollow nano-particle may be used in rubber composition, tire product, and pharmaceutical delivery system etc. | 2015-02-12 |
20150045464 | METHOD FOR PRODUCING RESIN FOAM, AND RESIN FOAM - A method for producing resin foam including: melting a resin composition including a polyolefin resin and a thermoplastic elastomer; impregnating the molten resin composition with a material that is a gas at normal temperature and normal pressure, in a supercritical state, under a condition in which the supercritical state of the material is maintained; foaming the resin composition impregnated with the material by arranging the resin composition under a condition in which the supercritical state of the material is not maintained; and hot-pressing the foamed resin composition. | 2015-02-12 |
20150045465 | Non-Film Forming Compositions and Methods of Protecting Cured Concrete and Cementitious Materials - Contemplated compositions and methods for protection of concrete and various other cementitious materials comprise a step of formation of a mesoporous polymeric network within the concrete or other cementitious material, wherein the network further includes a cationic component that forms a substantially insoluble precipitate upon reaction with sulfuric acid to so form a composite barrier against further attack by sulfuric acid. | 2015-02-12 |
20150045466 | EXPANDABLE POLYURETHANE COMPOSITION AND MANUFACTURING METHOD OF FLEXIBLE POLYURETHANE FOAM - An expandable polyurethane composition includes (A) polyisocyanate, (B) active hydrogen containing compound including (B1) polyol and (B2) water, a catalyst, and (C) one or more plasticizers selected from the group consisting of a monoester compound, a diester compound, a triester compound, and a tetraester compound by 0.5 to 20 parts by mass relative to 100 parts by mass of the (B1) polyol. A flexible polyurethane foam can be obtained of which wet set is improved and feeling is good. | 2015-02-12 |
20150045467 | METHOD FOR PRODUCING FOAM-MOLDED ARTICLE, AND FOAM-MOLDED ARTICLE - Even when a mixture resin of virgin resin and recovered resin material is used as a resin material for molding, a stable, high-quality foam-molded article with excellent impact resistance is produced at low cost. For this, the resin material that is used includes a mixture resin of recovered resin material obtained by pulverizing a resin material solidified after melting, and virgin resin without thermal history of melting, and a foaming agent added to the mixture resin. The resin material is a mixture of a polypropylene-based resin and a polyethylene-based elastomer. | 2015-02-12 |
20150045468 | METHOD FOR MANUFACTURING FOAM-MOLDED ARTICLE, AND FOAM-MOLDED ARTICLE - A foam-molded article has high weldability to a polypropylene-based resin molded article, a high expansion ratio, and a predetermined level of impact resistance despite using inexpensive polyethylene-based resin. The foam-molded article includes a foamed and molded base material resin in which a first polyethylene-based resin, a second polyethylene-based resin, and a polypropylene-based resin are mixed. The first polyethylene-based resin has a long-chain branched structure and a density of 0.920 g/cm | 2015-02-12 |
20150045469 | Plastics-Based Manufactured Article and Processes for Forming said Article - An oriented polymer composition (OPC) article comprising a body having a length, which is greater than any perpendicular dimension, comprised of an OPC having a softening temperature, the body having an outer surface extending the length of the body, having polymer strands aligned in the lengthwise direction of the body, wherein the length dimension stability is greater than 99% when tested by heating the article for 24 hours at temperatures at least up to and including 71 degrees Celsius after completion of the manufacture of the article and processes for forming said article. | 2015-02-12 |
20150045470 | ANTIBODY PURIFICATION METHOD, AND CARRIER FOR USE IN PURIFICATION OF ANTIBODY - An antibody purification method includes: bringing a solution that includes an antibody and has a pH of 3.0 or more and less than 5.6 into contact with a carrier that includes a 2,3-dihydroxypropyl group to adsorb the antibody on the carrier; and bringing the carrier that has been brought into contact with the solution, into contact with an eluent having a pH of 5.6 or more and less than 10 to elute the antibody from the carrier. | 2015-02-12 |
20150045471 | VISCOELASTIC SILICON RUBBER COMPOSITIONS - The invention provides for new viscoelastic silicone rubbers and compositions and methods for making and using them. The invention provides for viscoelastic silicone rubbers that are stiffer on short timescales than they are on long timescales. When subjected to brief stresses, they are relatively stiff and elastic, and they resist changing shapes. When subjected to sustain stresses, however, they are relatively soft and accommodating, and they gradually change shapes. When those stresses are removed, they gradually return to their original shapes. These viscoelastic silicone rubbers resist compression set and they are extremely resilient in response to sudden impacts. They can be dense rubbers, foam rubbers, and particles. | 2015-02-12 |
20150045472 | OLEFIN BASED POLYMER-COMBINED ORGANIC-INORGANIC COMPOSITE AND COMPOSITION FOR FORMING SAME - It is an object of the present invention to provide an anchor coating agent that can be used in one layer as an anchor coating for a base material and an inorganic material. An organic-inorganic hybrid coating composition that can be used as the anchor coating agent of the present invention contains the following components. a) an organic silicon compound which is at least one represented by formula (I) R | 2015-02-12 |
20150045473 | COMPOSITION FOR AFFIXING A COLORANT TO A SURFACE, PROTECTING A SURFACE, AND PROVIDING WEAR RESISTANCE TO A SURFACE - A composition includes a first solvent, a second solvent, a first surfactant for maintaining a dispersion of at least one of the first solvent and the second solvent, a first film forming polyurethane dispersion, a second film forming polyurethane dispersion, and a second surfactant for maintaining at least one of the first film forming polyurethane dispersion and the second film forming polyurethane dispersion. | 2015-02-12 |
20150045474 | MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PREPARING THE SAME - Disclosed are a modified conjugated diene polymer and a method for preparing the same. Provided are advantageously a modified conjugated diene polymer and a method for preparing the same which provide superior compatibility with an inorganic filler, heat generation, tensile strength and abrasion resistance, low fuel consumption and excellent resistance on wet roads. | 2015-02-12 |
20150045475 | PIGMENTS COATED IN AN ACID-RESISTANT MANNER - The invention relates to the use of pigments coated in an acid-resistant manner in PVC synthetic material. Acid-soluble pigments are provided with a coating of an organic compound that melts at a temperature of T>200° C., and as a result the otherwise acid-soluble pigments are still protected from HCl vapor even at PVC processing temperatures of between 180° C. and 200° C. | 2015-02-12 |
20150045476 | TWO PART SIZING COMPOSITION FOR COATING GLASS FIBRES AND COMPOSITE REINFORCED WITH SUCH GLASS FIBRES - A pellet comprising glass fibres and a thermoplastic polyester matrix, wherein the glass fibre at least partially has been coated with a two-part sizing composition comprising: (C) A precursor comprising: (a) an aminosilane and (b) a polymer or copolymer containing carboxylic acid and/or anhydride, both having a functionality, F≧3, and (D) A binder comprising a multifunctional epoxy resin of functionality, F≧3, and wherein the pellet has been subjected to a solid state post condensation process (SSPC). | 2015-02-12 |
20150045477 | POLY(PHENYLENE ETHER)/EPOXY HOMOGENEOUS SOLID AND POWDER COATING COMPOSITION INCORPORATING SAME - A homogeneous solid composition includes an aromatic epoxy resin and a poly(phenylene ether) having a number average molecular weight of 600 to 2000 atomic mass units and an average of 1.5 to 3 hydroxyl groups per molecule. The molecular weight and hydroxyl functionality of the poly(phenylene ether) allow it to be dissolved in the epoxy resin at relatively low temperature, and remain dissolved as the solution is cooled and solidified. The homogeneous solid composition facilitates incorporation of the poly(phenylene ether) into powder coating compositions that exhibit reduced water absorption in the cured state. | 2015-02-12 |
20150045478 | Polymer Composites with Silicon Dioxide Particles - Silicon dioxide particles can reinforce the mechanical properties of an epoxy matrix. Combining carbon nanotubes with the icon dioxide particles to co-reinforce the epoxy matrix achieves increases in compression strength, flexural strength, compression modulus, and flexural modulus. Such composites have increased mechanical properties over that of neat epoxy. | 2015-02-12 |
20150045479 | FILLED POLYPROPYLENE COMPOSITIONS AND RELATED AUTOMOTIVE COMPONENTS - The present disclosure provides a filled composition made from and/or containing (A) a first polymer composition made from and/or containing (i) a heterophasic polypropylene copolymer and (ii) a polypropylene blend, and (B) a biofiller composition made from and/or containing a cellulose-based biofiller. The filled composition can additionally be made with and/or contain an elastomeric ethylene copolymer composition. Optionally, the filled composition can further be made with and/or contains a grafted polyolefin composition. The filled composition is useful in making automotive components. | 2015-02-12 |
20150045480 | Starch-Based Hot Melt Adhesive - An exemplary embodiment of the present invention provides starch-based hot melt adhesive comprised of a composition including starch, a thermoplastic polymer, a tackifier, a plasticizer, and an adhesion promoter. The hot melt adhesive according to the exemplary embodiment of the present invention contains about 25 to 55 weight % of the starch which is infinitely renewable biomass, and, thus, it is less harmful and more eco-friendly and has a reduced manufacturing costs and is less sensitive to exhaustion of petroleum-based resources, as compared with the conventional hot melt adhesive mainly containing a petroleum-based material. Further, the hot melt adhesive according to the exemplary embodiment of the present invention imparts excellent adhesion strength and workability at the time of adhesion between different kinds of adherends such as a hydrophobic adherend and a hydrophilic adherend and can be applied to various fields such as packaging, bookbinding, construction, woodworking, and textile fields. | 2015-02-12 |
20150045481 | Asymmetric Diamine Compounds Containing Two Functional Groups and Polymers Therefrom - The present invention relates to a novel diamine compound, wherein two substituents R and R′ are introduced asymmetrically, and a polymer thereof. The polymer may have excellent solubility in the organic solvent and allows for easy processibility after imidization, thus giving proper film maintaining superior properties, such as thermal, mechanical, and optical properties for applications in electrical, electronic, or optical materials. | 2015-02-12 |
20150045482 | Pet Container and Compositions Having Enhanced Mechanical Properties and Gas Barrier Properties and Methods - A container comprising a polyester composition with enhanced mechanical properties is provided. The polyester composition comprises a polyester and a creep control agent. In particular embodiments, the polyester composition comprises a polyester, a creep control agent, and a gas barrier enhancing additive. In particular embodiments, the creep control agents are molecules or polymers comprising dianhydrides, bis-lactams, bis-oxazoles, and epoxides. | 2015-02-12 |
20150045483 | Resin Modifier, Polycarbonate Resin Composition and Molded Article Thereof - A polycarbonate resin composition and a molded article thereof are described, which have good flame retardance and high thermal stability when molded under high temperature. The resin composition contains a resin modifier (B) containing a tetrafluoroethylene-based polymer (p1) and a vinyl polymer (p2) other than the polymer (p1). The resin modifier (B) is obtained by using an alkaline (earth) metal salt other than a sulfate salt to segregate from a latex containing the polymer (p1) and the polymer (p2). The polymer (p2) is formed by performing polymerization on a vinyl monomer (X) containing at least 20 mass % of an aromatic vinyl monomer (x1) in the presence of at least one emulsifier selected from a phosphoric acid-based emulsifier, a carboxylic acid-based emulsifier, and a nonionic emulsifier. | 2015-02-12 |
20150045484 | AMINO GROUP-CONTAINING PHOSPHATE ESTER FLAME RETARDANT AND METHOD OF PREPARING THE SAME - The present invention relates to an amino group-containing phosphate ester flame retardant which has both a phosphate group and an amine group to exhibit a good flame retarding effect while overcoming the problems with the conventional phosphor-based flame retardants not having a good flame retarding effect with respect to its added amount, and a method of preparing the same. | 2015-02-12 |